256 related articles for article (PubMed ID: 29700117)
1. Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice.
He H; Wang J; Yannie PJ; Kakiyama G; Korzun WJ; Ghosh S
J Biol Chem; 2018 Jun; 293(24):9223-9231. PubMed ID: 29700117
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism.
Fuchs M; Hafer A; Münch C; Kannenberg F; Teichmann S; Scheibner J; Stange EF; Seedorf U
J Biol Chem; 2001 Dec; 276(51):48058-65. PubMed ID: 11673458
[TBL] [Abstract][Full Text] [Related]
3. Sterol Carrier Protein-2, a Nonspecific Lipid-Transfer Protein, in Intracellular Cholesterol Trafficking in Testicular Leydig Cells.
Li NC; Fan J; Papadopoulos V
PLoS One; 2016; 11(2):e0149728. PubMed ID: 26901662
[TBL] [Abstract][Full Text] [Related]
4. Liver-selective γ-secretase inhibition ameliorates diet-induced hepatic steatosis, dyslipidemia and atherosclerosis.
Kim K; Yu J; Kang JK; Morrow JP; Pajvani UB
Biochem Biophys Res Commun; 2020 Jul; 527(4):979-984. PubMed ID: 32439159
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of Bombyx mori sterol carrier protein x/sterol carrier protein 2 (SCPx/SCP2) gene.
Gong J; Hou Y; Zha XF; Lu C; Zhu Y; Xia QY
DNA Seq; 2006 Oct; 17(5):326-33. PubMed ID: 17343205
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat.
McLean MP; Billheimer JT; Warden KJ; Irby RB
Endocrinology; 1995 Aug; 136(8):3360-8. PubMed ID: 7628371
[TBL] [Abstract][Full Text] [Related]
7. Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr-/- mice.
Bie J; Wang J; Marqueen KE; Osborne R; Kakiyama G; Korzun W; Ghosh SS; Ghosh S
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1795-802. PubMed ID: 23744992
[TBL] [Abstract][Full Text] [Related]
8. Impact of dietary phytol on lipid metabolism in SCP2/SCPX/L-FABP null mice.
Milligan S; Martin GG; Landrock D; McIntosh AL; Mackie JT; Schroeder F; Kier AB
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Mar; 1862(3):291-304. PubMed ID: 27940000
[TBL] [Abstract][Full Text] [Related]
9. The role of hepatic Surf4 in lipoprotein metabolism and the development of atherosclerosis in apoE
Shen Y; Gu HM; Zhai L; Wang B; Qin S; Zhang DW
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Oct; 1867(10):159196. PubMed ID: 35803528
[TBL] [Abstract][Full Text] [Related]
10. Intracellular cholesterol transport proteins enhance hydrolysis of HDL-CEs and facilitate elimination of cholesterol into bile.
Wang J; Bie J; Ghosh S
J Lipid Res; 2016 Sep; 57(9):1712-9. PubMed ID: 27381048
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.
Mulvihill EE; Assini JM; Lee JK; Allister EM; Sutherland BG; Koppes JB; Sawyez CG; Edwards JY; Telford DE; Charbonneau A; St-Pierre P; Marette A; Huff MW
Diabetes; 2011 May; 60(5):1446-57. PubMed ID: 21471511
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.
Dikkers A; Annema W; de Boer JF; Iqbal J; Hussain MM; Tietge UJ
J Lipid Res; 2014 May; 55(5):816-25. PubMed ID: 24511105
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol enrichment enhances expression of sterol-carrier protein-2: implications for its function in intracellular cholesterol trafficking.
Kraemer R; Pomerantz KB; Kesav S; Scallen TJ; Hajjar DP
J Lipid Res; 1995 Dec; 36(12):2630-8. PubMed ID: 8847489
[TBL] [Abstract][Full Text] [Related]
14. Altered ovarian sterol carrier protein expression in the pregnant streptozotocin-treated diabetic rat.
McLean MP; Warden KJ; Sandhoff TW; Irby RB; Hales DB
Biol Reprod; 1996 Jul; 55(1):38-46. PubMed ID: 8793056
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice.
Thacker SG; Rousset X; Esmail S; Zarzour A; Jin X; Collins HL; Sampson M; Stonik J; Demosky S; Malide DA; Freeman L; Vaisman BL; Kruth HS; Adelman SJ; Remaley AT
J Lipid Res; 2015 Jul; 56(7):1282-95. PubMed ID: 25964513
[TBL] [Abstract][Full Text] [Related]
16. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
Park JG; Xu X; Cho S; Lee AH
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Expression of Niemann-Pick C1-Like 1, a Cholesterol Reabsorber from Bile, Exacerbates Western Diet-Induced Atherosclerosis in LDL Receptor Mutant Mice.
Yamamoto H; Yamanashi Y; Takada T; Mu S; Tanaka Y; Komine T; Suzuki H
Mol Pharmacol; 2019 Jul; 96(1):47-55. PubMed ID: 31064810
[TBL] [Abstract][Full Text] [Related]
18. Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.
Dong Z; Shi H; Zhao M; Zhang X; Huang W; Wang Y; Zheng L; Xian X; Liu G
Metabolism; 2018 Jun; 83():245-255. PubMed ID: 29526535
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Elovl5 leads to dyslipidemia and atherosclerosis in LDLR-deficient mice.
Bae S; Moon YA
Biochem Biophys Res Commun; 2024 Jan; 690():149292. PubMed ID: 38000296
[TBL] [Abstract][Full Text] [Related]
20. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
